Meningioma: all 233 studies
Page 1 of 3. Open to participants first (90), then studies with results posted, then the rest; newest registration first within each.
- Ceritinib Treatment for Recurrent MeningiomasNot yet recruitingNCT07893197Phase 2
- Preoperative Embolization for Highly Vascular Brain TumorsNot yet recruitingNCT07823985Not applicable
- Platform Research for Innovative Medicines in NF2-SWN (PRIME-NF2)Not yet recruitingNCT07713745Phase 2
- Luvometinib in Combination With Serplulimab for NF2-Related TumorsNot yet recruitingNCT07708285Phase 1/2
- Selumetinib for NF2-Related SchwannomatosisNot yet recruitingNCT07707947Phase 2
- IN10018 in Combination With Dalpiciclib for Progressive MeningiomasRecruitingNCT07652762Phase 1
- Diagnostic Performance and Quantitative Analysis of [18F]FET PET in Brain TumoursNot yet recruitingNCT07599917
- NK Cell Therapy for Malignant Solid Brain TumorsRecruitingNCT07552233Not applicable
- A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 MeningiomaRecruitingNCT07533942Phase 2
- ITM11 Expanded Access ProgramAvailableNCT07497984
- Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical ProceduresRecruitingNCT07493447Early Phase 1
- A Study of Zanzalintinib in Participants With Recurrent or Progressive MeningiomaRecruitingNCT07428616Phase 2
- Measurement of PSMA Expression in Vivo in Recurrent Meningiomas by PET Imaging: a Preliminary Study to a Therapeutic Trial Using Radioligand Therapy (RLT)Not yet recruitingNCT07428213Not applicable
- Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With MeningiomaRecruitingNCT07418775
- Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transdermal Interrupted SuturesRecruitingNCT07413796Not applicable
- Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial TumorsRecruitingNCT07411690
- Search for Circulating Tumour Cells in the Blood and/or Cerebrospinal Fluid in Patients With Recurrent Aggressive Meningiomas: Proof-of-concept StudyRecruitingNCT07398170Not applicable
- DEXmedetomidine for Postoperative Analgesia and Delirium Prevention After NEUROsurgery (DEX-NEURO Trial)Not yet recruitingNCT07398066Not applicable
- Psychometric Validation of the MQOL-FR and Descriptive Assessment of Quality of Life in Patients With MeningiomasNot yet recruitingNCT07376473
- γδ T-PD-1 Ab Cells in the Treatment of Malignant MeningiomaNot yet recruitingNCT07172178Early Phase 1
- RYZ101 for the Treatment of Progressive or Recurrent Intracranial MeningiomaRecruitingNCT07150806Phase 1/2
- Multicenter Trial on Surgical Outcome and Quality of Life in Juxta-medullary TumorsRecruitingNCT07056023
- Translation and Validation of the MQOL Self-questionnaire Into French for Assessing Quality of Life in Patients With MeningiomasRecruitingNCT07044076
- 3D MRE-Based Evaluation of Meningioma Mechanical Properties and Histological FeaturesRecruitingNCT06955208Not applicable
- Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior TreatmentRecruitingNCT06955169Phase 2
- DOTATATE PET for Meningioma Radiation PlanningNot yet recruitingNCT06937268Not applicable
- HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)RecruitingNCT06930846Not applicable
- SIMPLIFication of Care Pathways for Patients With Rare Brain Tumors Through Artificial IntelligenceRecruitingNCT06878469Not applicable
- The Impact of Endoscopic Endonasal Skull Base Surgery on OlfactionRecruitingNCT06874426
- Proton Versus Photon Radiotherapy in Adults With Primary Brain TumorsRecruitingNCT06831461Not applicable
- Somatostatin Receptor PET Imaging to Guide Radiotherapy Dose Escalation in High Risk Meningiomas.RecruitingNCT06830356Not applicable
- Pharmacoscopy for Patients With Refractory Primary Brain TumorsRecruitingNCT06804655Phase 2
- Proteomic Analysis of Patients Undergoing Bariatric SurgeryNot yet recruitingNCT06787807Not applicable
- Cryoablation of Brain NeoplasmEnrolling by invitationNCT06753617Not applicable
- Robot-Assisted Neurovascular InterventionRecruitingNCT06752096Not applicable
- A Phase II Study of SYHA1813 for Recurrent or Progressive High-Grade MeningiomaNot yet recruitingNCT06739213Phase 2
- Impact of Salovum® and SPC® Flakes on Brain Tumor Induced EdemaRecruitingNCT06710249Phase 2
- Meningioma and Embolism Thrombosis Risk & Investigation of CoagulationRecruitingNCT06709833
- FG001 in Subjects with Meningiomas or Presumed Low-Grade Gliomas Scheduled for NeurosurgeryRecruitingNCT06684795Phase 2
- Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain TumorsRecruitingNCT06650163Phase 1
- TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and MeningiomasRecruitingNCT06640582Phase 1/2
- A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive TumorsRecruitingNCT06632860Early Phase 1
- Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).RecruitingNCT06607692Phase 1/2
- Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk MeningiomaRecruitingNCT06557512Not applicable
- Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATERecruitingNCT06377371Phase 4
- 177Lu-DOTATATE for Recurrent MeningiomaRecruitingNCT06326190Phase 2
- Correlation Between Expression of Hormonal Receptors, Clinical Data, and Methylation Profile in Meningiomas (MethylRH-M)Enrolling by invitationNCT06278103
- Regorafenib for Recurrent Meningioma (MIRAGE Trial)RecruitingNCT06275919Phase 2
- Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS TrialRecruitingNCT06132685Phase 2
- Combination of Everolimus and 177Lu-DOTATATE in the Treatment of Grades 2 and 3 Refractory Meningioma: a Phase IIb Clinical TrialRecruitingNCT06126588Phase 2
- Plasma Extracellular Vesicles in Meningioma PatientsRecruitingNCT06104930Not applicable
- Neurocognitive Impact of Different Irradiation Modalities for Patients With Grade I-II Skull Base Meningioma:RecruitingNCT06036706Not applicable
- Feasibility of Acquiring Hyperpolarized Imaging in Patients With MeningiomaRecruitingNCT06014905Phase 1
- MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion AssessmentRecruitingNCT05957679Not applicable
- Abemaciclib in Newly Diagnosed Meningioma PatientsRecruitingNCT05940493Phase 2
- Cognition-preserving Brain Irradiation for Treating Patients With Intracranial Meningioma in the Era of Modern Radiotherapeutic Techniques Including Proton Beam Therapy - a Prospective Study Focusing on Radiological Outcomes and Neurocognitive EndpointsNot yet recruitingNCT05832099
- Predictive Factors for Survival in Aggressive MeningiomasRecruitingNCT05793034Not applicable
- Neurocognition After Radiotherapy in CNS- and Skull-base TumorsRecruitingNCT05727605Not applicable
- Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive TumorsRecruitingNCT05636618Phase 1/2
- Liquid Biopsy in High-grade Gliomas and MeningiomasRecruitingNCT05630664
- Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT PatientsRecruitingNCT05576103
- Sonography-guided Resection of Brain Mass LesionsRecruitingNCT05484245Not applicable
- Intraoperative Brain Shift Calculation StudyRecruitingNCT05477680Not applicable
- Cabozantinib for Patients With Recurrent or Progressive MeningiomaRecruitingNCT05425004Phase 2
- Embolization for MeningiomaRecruitingNCT05416567Not applicable
- Lutathera for Treatment of Recurrent or Progressive High-Grade CNS TumorsRecruitingNCT05278208Phase 1/2
- SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)RecruitingNCT05254197
- Intravenous Tranexamic Acid Reducing Intraoperative Blood Loss in Huge Meningiomas ResectionRecruitingNCT05230381Not applicable
- Evaluation of the CONVIVO SystemRecruitingNCT05139277Not applicable
- Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotideRecruitingNCT04997317Phase 1/2
- Exploratory Study of PD-1 Neoadjuvant Treatment of Recurrent MeningiomaRecruitingNCT04728568Not applicable
- Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncologyRecruitingNCT04648462
- Cognitive Status After Removal of Skull Base MeningiomaRecruitingNCT04635657
- Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System NeoplasmsRecruitingNCT04541082Phase 1
- Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in AdultsRecruitingNCT04501705Not applicable
- Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)RecruitingNCT04427384
- Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)RecruitingNCT04374305Phase 2
- Androcur® (Cyproterone Acetate) and Meningioma Development: a Genotype-environment Association StudyRecruitingNCT04372095
- UCSD Image-Guided Cognitive-Sparing Radiosurgery for Intracranial LesionsRecruitingNCT04343157Phase 2
- Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI StudyRecruitingNCT04278118Not applicable
- Multicenter Registry for Patients With Childhood.Onset Craniopharyngioma, Xanthogranuloma, Cysts of Rathke's Pouch, Meningioma, Pituitary Adenoma, Arachnoid CystsRecruitingNCT04158284
- Efficacy of Postoperative Radiotherapy for Atypical Meningioma Without Venous Sinus Invasion After Gross-total ResectionNot yet recruitingNCT04127760Not applicable
- Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine DepartmentRecruitingNCT04104529Not applicable
- Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation TherapyRecruitingNCT04082520Phase 2
- 68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.RecruitingNCT04081701Phase 4
- Liquid Biopsy Evaluation and Repository Development at Princess MargaretRecruitingNCT03702309
- Combination of Alpelisib and Trametinib in Progressive Refractory MeningiomasRecruitingNCT03631953Phase 1
- Proton Dose Escalation for Patients With Atypical or Anaplastic MeningiomasNot yet recruitingNCT02978677Not applicable
- Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive MeningiomasRecruitingNCT02523014Phase 2
- Natural History Study of Patients With Neurofibromatosis Type 2RecruitingNCT00598351
- Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas SystemCompletedNCT04743310Phase 2Results posted
- Gleolan for Visualization of Newly Diagnosed or Recurrent MeningiomaCompletedNCT04305470Phase 3Results posted
- Magnesium and Intraoperative Blood Loss in Meningioma SurgeryCompletedNCT03558516Phase 3Results posted
- Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade MeningiomaActive, not recruitingNCT03279692Phase 2Results posted
- Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC)CompletedNCT03273712Phase 2Results posted
- Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS CancersTerminatedNCT03173950Phase 2Results posted
- Trial of Selumetinib in Patients With Neurofibromatosis Type II Related TumorsTerminatedNCT03095248Phase 2Results posted
- A Trial of Pembrolizumab for Refractory Atypical and Anaplastic MeningiomaTerminatedNCT03016091Phase 2Results posted
- Proton/Photon Rt - Benign Meningiomas(P92-13)CompletedNCT02947984Phase 3Results posted
- AZD2014 In NF2 Patients With Progressive or Symptomatic MeningiomasCompletedNCT02831257Phase 2Results posted